These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23221654)
1. [A meta-analysis of chemotherapy related cognitive impairment in patients with breast cancer]. Park JH; Bae SH J Korean Acad Nurs; 2012 Oct; 42(5):644-58. PubMed ID: 23221654 [TBL] [Abstract][Full Text] [Related]
2. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700 [TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Stewart A; Bielajew C; Collins B; Parkinson M; Tomiak E Clin Neuropsychol; 2006 Feb; 20(1):76-89. PubMed ID: 16410227 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128 [TBL] [Abstract][Full Text] [Related]
5. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112 [TBL] [Abstract][Full Text] [Related]
6. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671 [TBL] [Abstract][Full Text] [Related]
7. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Quesnel C; Savard J; Ivers H Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633 [TBL] [Abstract][Full Text] [Related]
8. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787 [TBL] [Abstract][Full Text] [Related]
9. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Stewart A; Collins B; Mackenzie J; Tomiak E; Verma S; Bielajew C Psychooncology; 2008 Feb; 17(2):122-30. PubMed ID: 17518411 [TBL] [Abstract][Full Text] [Related]
10. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Hodgson KD; Hutchinson AD; Wilson CJ; Nettelbeck T Cancer Treat Rev; 2013 May; 39(3):297-304. PubMed ID: 23219452 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. Vardy J; Rourke S; Tannock IF J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710 [TBL] [Abstract][Full Text] [Related]
13. Cognitive adverse effects of chemotherapy in breast cancer patients. Correa DD; Ahles TA Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726 [TBL] [Abstract][Full Text] [Related]
14. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Jansen CE; Miaskowski C; Dodd M; Dowling G; Kramer J Cancer; 2005 Nov; 104(10):2222-33. PubMed ID: 16206292 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. Dutta V J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805 [TBL] [Abstract][Full Text] [Related]
16. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations. Cheung YT; Chui WK; Chan A Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329 [TBL] [Abstract][Full Text] [Related]
17. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test. Prokasheva S; Faran Y; Cwikel J; Geffen DB J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931 [TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives. Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588 [TBL] [Abstract][Full Text] [Related]
19. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331 [TBL] [Abstract][Full Text] [Related]
20. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]